Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)

Breast. 2014 Dec;23(6):807-11. doi: 10.1016/j.breast.2014.08.013. Epub 2014 Sep 28.

Abstract

Despite surgical removal of ductal carcinoma in situ (DCIS), recurrences still occur. This retrospective cohort study evaluated the risk of invasive recurrence following surgery and investigated factors which may be predictive of recurrence. We specifically investigated invasive recurrence with respect to mode of detection of DCIS. Patients whose DCIS was detected outside of the NHS Breast Screening Programme have a higher risk of subsequent ipsilateral invasive breast cancer than those whose DCIS is detected through screening. There is no significant difference in risk of subsequent contralateral invasive recurrence according to mode of detection.

Keywords: Breast cancer; DCIS; NHSBSP (NHS breast screening programme); Radiotherapy; Recurrence.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / therapy*
  • Carcinoma, Ductal, Breast*
  • Carcinoma, Intraductal, Noninfiltrating / diagnosis
  • Carcinoma, Intraductal, Noninfiltrating / epidemiology
  • Carcinoma, Intraductal, Noninfiltrating / therapy*
  • Early Detection of Cancer
  • Female
  • Humans
  • Mastectomy
  • Mastectomy, Segmental
  • Middle Aged
  • Neoplasm Recurrence, Local*
  • Neoplasms, Second Primary*
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Risk
  • Treatment Outcome
  • United Kingdom
  • Young Adult